These findings indicated that pre- and posttreatment with edaravone enhances neurogenesis by protecting NSPCs from apoptosis, probably mediated by decreasing ROS generation and inhibiting the protein expression of HIF-1α and cleaved caspase-3 after cerebral ischemia. Here, HIF1A is linked to brain ischemia.